நோயாளிகள் உடன் பல ஸ்க்லரோசிஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நோயாளிகள் உடன் பல ஸ்க்லரோசிஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நோயாளிகள் உடன் பல ஸ்க்லரோசிஸ் Today - Breaking & Trending Today

#AANAM – Tysabri in MS Improves Quality of Life, Reduces Infection Risk


Click here to subscribe to the Multiple Sclerosis News Today Newsletter!
5
(2)
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference.
Treatment with Tysabri (natalizumab) can improve mental and social health in people with multiple sclerosis (MS), according to new data presented at the 2021 virtual American Academy of Neurology annual meeting (AANAM).
Data presented at AANAM also indicate that less frequent dosing of Tysabri can reduce the risk of rare brain infections, while still lowering MS disease activity.
Tysabri, by Biogen, is an approved treatment for relapsing forms of MS, and works by blocking inflammatory immune cells from getting into the brain. In clinical trials, Tysabri has been demonstrated to lower the rate of MS relapses and to ease symptoms. Treatment with Tysabri also h ....

United States , Maha Radhakrishnan , Carrie Hersh , Program Database , University Of Lisbon , Ms Partners Advancing Technology , Biomedical Sciences , Society Of America , University Of Pittsburgh , American Academy Of Neurology , Health Solutions , Multiple Sclerosis News Today , American Academy , Cleveland Clinic , Real World Cohort , Patients With Multiple Sclerosis , Advancing Technology , Neurological Disorders , Extended Interval Dosing , Reduced Risk , Progressive Multifocal Leukoencephalopathy , Updated Analysis , Molecular Pathology , Molecular Biology , Universidade Nova De Lisboa , Managing Science Editor ,

Racial disparities present in MS treatment, disability severity


Racial disparities present in MS treatment, disability severity
Source:
Rivera V, et al. Sociodemographic and Clinical Characteristics of Patients With Multiple Sclerosis by Race and Ethnicity (NARCRMS Registry). Presented at: American Academy of Neurology Annual Meeting; April 17-22, 2021 (virtual meeting).
Disclosures:
Rivera reports receiving honoraria from Biogen, EMD Serono and Roche.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Subscribe
ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published. ....

United States , Madison Weller , Victor Rivera , American Academy Of Neurology Annual Meeting , American Academy Of Neurology , Baylor College Of Medicine , Clinical Characteristics , Patients With Multiple Sclerosis , American Academy , Neurology Annual Meeting , African American , Baylor College , ஒன்றுபட்டது மாநிலங்களில் , மாடிசன் வெல்லர் , வெற்றியாளர் ரிவேரா , அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் ஆண்டு சந்தித்தல் , அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் , பேலர் கல்லூரி ஆஃப் மருந்து , மருத்துவ பண்புகள் , நோயாளிகள் உடன் பல ஸ்க்லரோசிஸ் , அமெரிக்கன் கலைக்கழகம் , நரம்பியல் ஆண்டு சந்தித்தல் , பேலர் கல்லூரி ,

More MS Disability, Age, Race Linked With Worse COVID-19 Outcomes